Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Alan Sweetser, M.D.,Ph.D.

Concepts (456)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with David Sweetser's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that David Sweetser has written about over time.
Leukemia, Myeloid, 3 publications between 2001 and 2016, average publication date October 2007. Genes, Tumor Suppressor, 4 publications between 2001 and 2016, average publication date January 2010. Abnormalities, Multiple, 4 publications between 1993 and 2019, average publication date July 2011. Co-Repressor Proteins, 3 publications between 2008 and 2018, average publication date March 2014. Repressor Proteins, 4 publications between 2008 and 2018, average publication date June 2014. Bone Development, 1 publications between 2014 and 2014, average publication date August 2014. Phenotype, 15 publications between 1995 and 2023, average publication date October 2014. Genetic Diseases, X-Linked, 1 publications between 2016 and 2016, average publication date May 2016. Guanine Nucleotide Exchange Factors, 1 publications between 2016 and 2016, average publication date May 2016. Wnt Proteins, 1 publications between 2016 and 2016, average publication date July 2016. Homocystinuria, 1 publications between 2016 and 2016, average publication date November 2016. Myopia, 1 publications between 2016 and 2016, average publication date November 2016. Muscle Hypotonia, 4 publications between 2016 and 2021, average publication date December 2018. NF-kappa B, 2 publications between 2016 and 2022, average publication date April 2019. Mutation, Missense, 10 publications between 2016 and 2024, average publication date September 2020. Microcephaly, 4 publications between 2017 and 2023, average publication date January 2021. Spasms, Infantile, 1 publications between 2021 and 2021, average publication date June 2021. Ubiquitin-Activating Enzymes, 2 publications between 2021 and 2023, average publication date September 2022.

To see the data from this visualization as text, click here.
Sweetser's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (456)
Explore
_
Co-Authors (127)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.